Aktiv Pharma Group

www.aktivpharmagroup.com

Formerly Aktivax Inc.

High-Tech Company

TECH VERTICALS

Healthtech, Life Sciences, Medical Devices, Medical Equipment, MedTech

General Data

Sector	Medical Devices
Company Stage:	R&D
Established	2009
Number of Employees	28

DESCRIPTION

Aktivax brings peace of mind to people at risk and their communities by developing simple-to-use emergency treatment technologies. Initially developed for the military, the ARAI™ is a prefilled auto-injector that uses single-hand, single-step activation. Now, ARAI is being developed to help people with life-threatening conditions in emergency situations, such as hypoglycemia, anaphylaxis and opioid overdose.

TECHNOLOGY

Auto-injector

Products and Phases

Product	Phase
PenPal
PenPal® seamlessly integrates exceptional design simplicity with superior performance, reliability, and platform versatility. Our vision is to leverage our capabilities and innovative PenPal® autoinjector technology to support pharmaceutical and biopharmaceutical partners in need of high-performance autoinjectors. We are dedicated to addressing underserved market segments that require injection dose volumes larger than 2.25 ml and/or high-viscosity formulations.

	TARGET MARKETS
	Their initial focus is on delivering improved solutions to the following conditions, which represent more than $2 billion in market opportunity: Opioid overdose Anaphylaxis Hypoglycemia

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Broomfield, United States

Address	100 Technology Drive, Suite 250A
City	Broomfield
State/Province	CO
Country	United States
Zip	80304-0848

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Amir Genosar	CEO & Founder
Mr. Greg Langley	CTO

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Chief Strategy Officer, BARALAN

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Venture Lending

Mar. 21, 2012

R&D

abCDe

Last Updated:	abCDe
IVC Number:	abCDe